{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:24:22Z","timestamp":1790767462698,"version":"4.1.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R44NS095423"],"award-info":[{"award-number":["R44NS095423"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5U54HD090254"],"award-info":[{"award-number":["5U54HD090254"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["U34AR068616"],"award-info":[{"award-number":["U34AR068616"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003222","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T13:34:04Z","timestamp":1600695244000},"page":"e1003222","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Efficacy and safety of vamorolone in Duchenne muscular dystrophy:\u00a0An 18-month interim analysis of a non-randomized open-label extension study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-9377","authenticated-orcid":true,"given":"Edward C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie S.","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-5139","authenticated-orcid":true,"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-7054","authenticated-orcid":true,"given":"Richard S.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tulinius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-2207","authenticated-orcid":true,"given":"Richard","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0690-5786","authenticated-orcid":true,"given":"Laurie","family":"Kerchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren P.","family":"Morgenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2583-8585","authenticated-orcid":true,"given":"Adrienne","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Shimony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-1174","authenticated-orcid":true,"given":"Phil","family":"Shale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2330-5427","authenticated-orcid":true,"given":"Heather","family":"Gordish-Dressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-0697","authenticated-orcid":true,"given":"Laura","family":"Hagerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-2015","authenticated-orcid":true,"given":"Utkarsh J.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Damsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-9478","authenticated-orcid":true,"given":"Benjamin D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel J.","family":"Mengle-Gaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-3220","authenticated-orcid":true,"given":"Craig M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CINRG VBP15 and DNHS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"pmed.1003222.ref001","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1124\/mol.119.116806","article-title":"First high-resolution crystal structures of the glucocorticoid receptor ligand-binding domain-peroxisome proliferator-activated \u03b3 coactivator 1-\u03b1 complex with endogenous and synthetic glucocorticoids","volume":"96","author":"X Liu","year":"2019","journal-title":"Mol Pharmacol"},{"key":"pmed.1003222.ref002","article-title":"Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment","author":"A Liu","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pmed.1003222.ref003","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"CR Heier","year":"2013","journal-title":"EMBO Mol Med"},{"key":"pmed.1003222.ref004","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00011-019-01279-z","article-title":"Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset","volume":"68","author":"JM Damsker","year":"2019","journal-title":"Inflamm Res"},{"issue":"1","key":"pmed.1003222.ref005","doi-asserted-by":"crossref","first-page":"e201800186","DOI":"10.26508\/lsa.201800186","article-title":"Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy","volume":"2","author":"CR Heier","year":"2019","journal-title":"Life Sci Alliance"},{"key":"pmed.1003222.ref006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pupt.2016.04.004","article-title":"A novel dissociative steroid VBP15 reduces MUC5AC gene expression in airway epithelial cells but lacks the GRE mediated transcriptional properties of dexamethasone","volume":"38","author":"LM Garvin","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"pmed.1003222.ref007","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.ymthe.2018.07.021","article-title":"Membrane stabilization by modified steroid offers a potential therapy for muscular dystrophy due to dysferlin deficit","volume":"26","author":"SC Sreetama","year":"2018","journal-title":"Mol Ther"},{"key":"pmed.1003222.ref008","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"YW Chen","year":"2005","journal-title":"Neurology"},{"key":"pmed.1003222.ref009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.steroids.2018.02.010","article-title":"Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes","volume":"134","author":"EP Hoffman","year":"2018","journal-title":"Steroids"},{"key":"pmed.1003222.ref010","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"AS Rosenberg","year":"2015","journal-title":"Sci Transl Med"},{"key":"pmed.1003222.ref011","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"LS Conklin","year":"2018","journal-title":"Pharmacol Res"},{"key":"pmed.1003222.ref012","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/jcph.1388","article-title":"Population pharmacokinetics of vamorolone (VBP15) in healthy men and boys with Duchenne muscular dystrophy","volume":"59","author":"PD Mavroudis","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"pmed.1003222.ref013","article-title":"Exposure-response analysis of vamorolone (VBP15) in boys with Duchenne muscular dystrophy","author":"X Li","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"pmed.1003222.ref014","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000008168","article-title":"Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function","volume":"93","author":"EP Hoffman","year":"2019","journal-title":"Neurology"},{"key":"pmed.1003222.ref015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.23807","article-title":"The CINRG Duchenne Natural History Study\u2014a longitudinal natural history study in the era of glucocorticoid therapy: design of the protocol and methods","volume":"48","author":"CM McDonald","year":"2013","journal-title":"Muscle Nerve"},{"key":"pmed.1003222.ref016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"CM McDonald","year":"2018","journal-title":"Lancet"},{"key":"pmed.1003222.ref017","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy","volume":"77","author":"DM Escolar","year":"2011","journal-title":"Neurology"},{"key":"pmed.1003222.ref018","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"L Bello","year":"2015","journal-title":"Neurology"},{"key":"pmed.1003222.ref019","article-title":"Serum biomarkers associated with baseline clinical severity in young steroid-naive Duchenne muscular dystrophy boys","author":"CINRG Vamorolone 002\/003 Investigators","year":"2020","journal-title":"Hum Mol Genet"},{"key":"pmed.1003222.ref020","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/WNL.0000000000003217","article-title":"Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy","volume":"87","author":"RC Griggs","year":"2016","journal-title":"Neurology"},{"key":"pmed.1003222.ref021","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-014-0133-y","article-title":"VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis","volume":"35","author":"BC Dillingham","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"pmed.1003222.ref022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s002280050160","article-title":"Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects","volume":"51","author":"G Babadjanova","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"pmed.1003222.ref023","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/kem030","article-title":"Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study","volume":"46","author":"G Saviola","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T13:34:17Z","timestamp":1600695257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003222"}},"subtitle":[],"editor":[{"given":"Lindsay N.","family":"Alfano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003222","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]}}}